JUNO THERAPEUTICS INC's ticker is JUNO and the CUSIP is 48205A109. A total of 176 filers reported holding JUNO THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 0.85 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $1,061,000 | +314.5% | 23,649 | +175.7% | 0.10% | +300.0% |
| Q2 2017 | $256,000 | +9.9% | 8,578 | -18.3% | 0.02% | +9.1% |
| Q1 2017 | $233,000 | +145.3% | 10,500 | +108.2% | 0.02% | +100.0% |
| Q4 2016 | $95,000 | +9400.0% | 5,044 | +25120.0% | 0.01% | – |
| Q3 2016 | $1,000 | -94.7% | 20 | -96.0% | 0.00% | -100.0% |
| Q2 2016 | $19,000 | +72.7% | 500 | +66.7% | 0.00% | +50.0% |
| Q1 2016 | $11,000 | -59.3% | 300 | -40.0% | 0.00% | -50.0% |
| Q2 2015 | $27,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 25,948,799 | $1,132,937,000 | 100.00% |
| Biomark Capital Management Co. LLC | 1,602,562 | $70,465,000 | 85.76% |
| Omega Fund Management, LLC | 1,229,512 | $54,062,000 | 30.09% |
| Clarius Group, LLC | 218,942 | $9,626,000 | 2.93% |
| BB BIOTECH AG | 1,305,000 | $57,381,000 | 1.62% |
| Casdin Capital, LLC | 17,500 | $769,000 | 0.68% |
| Rock Springs Capital Management LP | 197,001 | $8,662,000 | 0.66% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 38,850 | $1,708,000 | 0.55% |
| ArrowMark Colorado Holdings LLC | 383,749 | $16,873,000 | 0.46% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 68,848 | $3,027,000 | 0.38% |